iifl-logo

Unichem Laboratories Ltd Balance Sheet

Add as a Preferred Source on Google
593.5
(-0.35%)
Jul 21, 2026|12:49:51 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

14.08

14.08

14.08

14.08

Preference Capital

0

0

0

0

Reserves

2,613.02

2,445.67

2,280.55

2,370.19

Net Worth

2,627.1

2,459.75

2,294.63

2,384.27

Minority Interest

Debt

64.08

122.7

70.3

108.26

Deferred Tax Liability Net

91.28

82.07

0

0

Total Liabilities

2,782.46

2,664.52

2,364.93

2,492.53

Fixed Assets

1,289.98

1,305.72

1,287.3

1,383.76

Intangible Assets

Investments

47.49

45.62

44.08

40.51

Deferred Tax Asset Net

18.83

62.2

0

0

Networking Capital

1,168.27

1,162.35

904.49

910.96

Inventories

592.48

584.06

500.53

480.19

Inventory Days

Sundry Debtors

582.94

748.14

558.41

472.08

Debtor Days

Other Current Assets

321.67

337.04

322.13

352.31

Sundry Creditors

-239.43

-291.88

-253.25

-254.37

Creditor Days

Other Current Liabilities

-89.39

-215.01

-223.33

-139.25

Cash

257.89

88.63

129.06

157.28

Total Assets

2,782.46

2,664.52

2,364.93

2,492.51

Unichem Labs. : related Articles

Top Stocks for Today - 19th September 2025

Here are some of the stocks that may see significant price movement today: Texmaco Rail, Vedanta, Unichem Laboratories, etc.

19 Sep 2025|07:24 AM
Read More
Unichem Labs Q3 Profit Drops 20.5% YoY, Revenue Up 14.5%

Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.

6 Feb 2025|10:48 PM
Read More
Unichem Labs plans to consolidate US generic formulations bizz

Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.

23 Sep 2024|03:02 PM
Read More
Unichem Labs Goa facility gets 5 observations from USFDA

According to the corporation, the observations have no influence on business continuity or supplies to the US market.

16 Jul 2024|11:11 AM
Read More
Top 10 stocks for today - 16th July, 2024

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

16 Jul 2024|08:47 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.